Patents by Inventor Jhy-Jhu Lin

Jhy-Jhu Lin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10195237
    Abstract: The present invention provides a method of treating a disease or condition characterized by inflammation in a subject in need thereof, comprising administering to the subject an effective amount of a Pediococcus acidilactici probiotic. Compositions of Pediococcus acidilactici probiotic are also provided.
    Type: Grant
    Filed: March 16, 2016
    Date of Patent: February 5, 2019
    Assignee: IMAGILIN TECHNOLOGY LLC
    Inventors: Jhy-Jhu Lin, Jolinta Lin
  • Patent number: 9789141
    Abstract: This invention relates to use of probiotics, particularly P acidilactici and S boulardii, for use in conjunction with steroids and other immune suppressor agents to ameliorate symptoms of autoimmune diseases, especially disease symptoms arising from the body's production of antibodies against autologous blood cells. The practice of the invention sustains ameliorative response associated with immune suppressor agents while lowering the amount of immune suppressor agents required for treatment.
    Type: Grant
    Filed: May 6, 2016
    Date of Patent: October 17, 2017
    Assignee: IMAGILIN TECHNOLOGY, LLC
    Inventors: Jhy-Jhu Lin, Gen Kato, Takuo Ishida
  • Publication number: 20170143777
    Abstract: The present invention provides compositions comprising a probiotc in admixture with an effective amount of an amphipathic substance that enhances viability of the probiotic in the composition when the composition is subjected to heat.
    Type: Application
    Filed: November 30, 2016
    Publication date: May 25, 2017
    Inventors: Jhy-Jhu Lin, Jolinta Lin
  • Publication number: 20170020929
    Abstract: The present invention provides a method of treating a disease or condition characterized by inflammation in a subject in need thereof, comprising administering to the subject an effective amount of a Pediococcus acidilactici probiotic. Compositions of Pediococcus acidilactici probiotic are also provided.
    Type: Application
    Filed: March 16, 2016
    Publication date: January 26, 2017
    Inventors: Jhy-Jhu Lin, Jolinta Lin
  • Publication number: 20160243173
    Abstract: This invention relates to use of probiotics, particularly P acidilactici and S boulardii, for use in conjunction with steroids and other immune suppressor agents to ameliorate symptoms of autoimmune diseases, especially disease symptoms arising from the body's production of antibodies against autologous blood cells. The practice of the invention sustains ameliorative response associated with immune suppressor agents while lowering the amount of immune suppressor agents required for treatment.
    Type: Application
    Filed: May 6, 2016
    Publication date: August 25, 2016
    Applicant: IMAGILIN TECHNOLOGY, LLC
    Inventors: Jhy-Jhu LIN, Gen KATO, Takuo ISHIDA
  • Publication number: 20160193259
    Abstract: A Pediococcus acidilactici strain that survives incubation for 24 hours at 85° C. and multiplies more than 800 fold after subsequent overnight incubation at 50° C.
    Type: Application
    Filed: February 10, 2016
    Publication date: July 7, 2016
    Applicant: IMAGILIN TECHNOLOGY, LLC.
    Inventors: Jhy-Jhu LIN, Susheel Bhanu BUSI
  • Patent number: 9364507
    Abstract: This invention relates to use of probiotics, particularly P acidilactici and S boulardii, for use in conjunction with steroids and other immune suppressor agents to ameliorate symptoms of autoimmune diseases, especially disease symptoms arising from the body's production of antibodies against autologous blood cells. The practice of the invention sustains ameliorative response associated with immune suppressor agents while lowering the amount of immune suppressor agents required for treatment.
    Type: Grant
    Filed: August 11, 2010
    Date of Patent: June 14, 2016
    Assignee: IMAGILIN TECHNOLOGY, LLC
    Inventors: Jhy-Jhu Lin, Gen Kato, Takuo Ishida
  • Patent number: 9289008
    Abstract: A Pediococcus acidilactici strain that is viable at temperatures above 65° C., is able to grow in aerobic and anaerobic conditions, and in a pH range between 1 and 6.2 and a consumable food product containing same.
    Type: Grant
    Filed: November 14, 2012
    Date of Patent: March 22, 2016
    Assignee: Imaglin Technology, LLC
    Inventors: Jhy-Jhu Lin, Susheel Bhanu Busi
  • Publication number: 20150246082
    Abstract: A method of augmenting a weight-loss regimen composition comprising administering at least one billion P. acidilactici NRRL B-50517 daily in a carrier.
    Type: Application
    Filed: May 15, 2015
    Publication date: September 3, 2015
    Inventor: Jhy-Jhu LIN
  • Publication number: 20140193464
    Abstract: A dry, stable and viable probiotic composition comprising, a probiotic microorganism and a dried plant powder, with the proviso that said composition is not a blended mixture of at least one biologically pure Pediococcus acidilactici probiotic culture and dried tomato powder at a weight ratio of 1:4 encapsulated in an effective amount in a gelatin capsule.
    Type: Application
    Filed: January 8, 2013
    Publication date: July 10, 2014
    Applicant: IMAGILIN TECHNOLOGY, LLC
    Inventor: Jhy-Jhu Lin
  • Patent number: 8496923
    Abstract: An exemplary embodiment providing one or more improvements includes feeding animals with probiotic microbes encapsulated in a mixture of xanthan gum and chitosan, or in gelatin, specifically Pediococcus acidilactici and Saccharomyces boulardii. Such encapsulation protects the viability of the probiotic microbes against unfavorable temperatures. An exemplary embodiment providing one or more improvements includes methods of using viable probiotics in therapy of birds and mammals infected with infectious diseases. Probiotics acted as adjuvants in stimulating antibody reaction and stimulated a cellular immunity response. In particular, probiotics were shown to reduce the number of viable oocytes from fecal samples, stimulate antibody production, and stimulate of proliferation of splenocytes in chickens infected with Eimeria. In addition, probiotics were shown to relieve symptoms of parvovirus infection in dogs.
    Type: Grant
    Filed: November 2, 2010
    Date of Patent: July 30, 2013
    Assignee: Imagilin Technology, LLC.
    Inventor: Jhy-Jhu Lin
  • Publication number: 20130064885
    Abstract: An exemplary embodiment providing one or more improvements includes feeding animals with probiotic microbes encapsulated in a mixture of xanthan gum and chitosan, or in gelatin, specifically Pediococcus acidilactici and Saccharomyces boulardii. Such encapsulation protects the viability of the probiotic microbes against unfavorable temperatures. An exemplary embodiment providing one or more improvements includes methods of using viable probiotics in therapy of birds and mammals infected with infectious diseases. Probiotics acted as adjuvants in stimulating antibody reaction and stimulated a cellular immunity response. In particular, probiotics were shown to reduce the number of viable oocytes from fecal samples, stimulate antibody production, and stimulate of proliferation of splenocytes in chickens infected with Elimeria. In addition, probiotics were shown to relieve symptoms of parvovirus infection in dogs.
    Type: Application
    Filed: September 10, 2012
    Publication date: March 14, 2013
    Inventors: Jhy-Jhu Lin, Jolinta Lin
  • Patent number: 8318152
    Abstract: An exemplary embodiment providing one or more improvements includes probiotic compositions comprising probiotic microorganisms with dried vegetable, fruit, cereal, or herb powder. Feeding human or animals either having biological or environmental changes with probiotic compositions has a positive effect in relieving the changes. Positive effects has been demonstrated in humans, dogs, and fish.
    Type: Grant
    Filed: April 16, 2009
    Date of Patent: November 27, 2012
    Assignee: Imagilin Technology, LLC
    Inventor: Jhy-Jhu Lin
  • Publication number: 20110151511
    Abstract: The present invention provides novel rapidly growing microorganisms and methods for their use in cloning or subcloning nucleic acid molecules. The rapid growing microorganisms of the present invention form colonies more rapidly than microorganisms typically used in molecular biology and thus provide a significant improvement in in vitro cloning methods used extensively in molecular biology. The invention also relates to kits and compositions used in the methods of the invention.
    Type: Application
    Filed: December 17, 2010
    Publication date: June 23, 2011
    Applicant: LIFE TECHNOLOGIES CORPORATION
    Inventors: Frederic R. Bloom, Brian J. Schmidt, Jhy-Jhu Lin
  • Publication number: 20110129518
    Abstract: An exemplary embodiment providing one or more improvements includes feeding animals with probiotic microbes encapsulated in a mixture of xanthan gum and chitosan, or in gelatin, specifically Pediococcus acidilactici and Saccharomyces boulardii. Such encapsulation protects the viability of the probiotic microbes against unfavorable temperatures. An exemplary embodiment providing one or more improvements includes methods of using viable probiotics in therapy of birds and mammals infected with infectious diseases. Probiotics acted as adjuvants in stimulating antibody reaction and stimulated a cellular immunity response. In particular, probiotics were shown to reduce the number of viable oocytes from fecal samples, stimulate antibody production, and stimulate of proliferation of splenocytes in chickens infected with Eimeria. In addition, probiotics were shown to relieve symptoms of parvovirus infection in dogs.
    Type: Application
    Filed: November 2, 2010
    Publication date: June 2, 2011
    Applicant: IMAGILIN TECHNOLOGY LLC
    Inventor: Jhy-Jhu Lin
  • Publication number: 20110129529
    Abstract: An exemplary embodiment providing one or more improvements includes feeding animals with probiotic microbes encapsulated in a mixture of xanthan gum and chitosan, or in gelatin, specifically Pediococcus acidilactici and Saccharomyces boulardii. Such encapsulation protects the viability of the probiotic microbes against unfavorable temperatures. An exemplary embodiment providing one or more improvements includes methods of using viable probiotics in therapy of birds and mammals infected with infectious diseases. Probiotics acted as adjuvants in stimulating antibody reaction and stimulated a cellular immunity response. In particular, probiotics were shown to reduce the number of viable oocytes from fecal samples, stimulate antibody production, and stimulate of proliferation of splenocytes in chickens infected with Elimeria. In addition, probiotics were shown to relieve symptoms of parvovirus infection in dogs.
    Type: Application
    Filed: November 2, 2010
    Publication date: June 2, 2011
    Applicant: IMAGILIN TECHNOLOGY LLC
    Inventor: Jhy-Jhu Lin
  • Patent number: 7935334
    Abstract: An exemplary embodiment providing one or more improvements includes feeding animals with probiotic microbes encapsulated in a mixture of xanthan gum and chitosan, or in gelatin, specifically Pediococcus acidilactici and Saccharomyces boulardii. Such encapsulation protects the viability of the probiotic microbes against unfavorable temperatures. An exemplary embodiment providing one or more improvements includes methods of using viable probiotics in therapy of birds and mammals infected with infectious diseases. Probiotics acted as adjuvants in stimulating antibody reaction and stimulated a cellular immunity response. In particular, probiotics were shown to reduce the number of viable oocytes from fecal samples, stimulate antibody production, and stimulate of proliferation of splenocytes in chickens infected with Elimeria. In addition, probiotics were shown to relieve symptoms of parvovirus infection in dogs.
    Type: Grant
    Filed: July 26, 2006
    Date of Patent: May 3, 2011
    Assignee: Imagilin Technologies, LLC
    Inventor: Jhy-Jhu Lin
  • Publication number: 20110038838
    Abstract: Embodiment include methods for treating cats and dogs with inflammatory bowl disease or inflammatory-like bowl disease or immune mediated hemolytic anemia or atopic dermatitis which are being treated with steroids or immune suppressors which involves the step of administering to the animal a probiotic comprised of P. acidilactici and S. boulardii microorganisms for the purpose of reducing the amount of steroid or immune suppressor required to ameliorate the symptoms of the diseases or conditions.
    Type: Application
    Filed: August 11, 2010
    Publication date: February 17, 2011
    Applicant: IMAGILIN TECHNOLOGY, LLC
    Inventors: Jhy-Jhu Lin, Gen Kato, Takuo Ishida
  • Patent number: 7858358
    Abstract: The present invention provides novel rapidly growing microorganisms and methods for their use in cloning or subcloning nucleic acid molecules. The rapid growing microorganisms of the present invention form colonies more rapidly than microorganisms typically used in molecular biology and thus provide a significant improvement in in vitro cloning methods used extensively in molecular biology. The invention also relates to kits and compositions used in the methods of the invention.
    Type: Grant
    Filed: February 22, 2007
    Date of Patent: December 28, 2010
    Assignee: Life Technologies Corp.
    Inventors: Frederic R Bloom, Brian J Schmidt, Jhy-Jhu Lin
  • Publication number: 20090263366
    Abstract: An exemplary embodiment providing one or more improvements includes probiotic compositions comprising probiotic microorganisms with dried vegetable, fruit, cereal, or herb powder. Feeding human or animals either having biological or environmental changes with probiotic compositions has a positive effect in relieving the changes. Positive effects has been demonstrated in humans, dogs, and fish.
    Type: Application
    Filed: April 16, 2009
    Publication date: October 22, 2009
    Applicant: Imagilin Technology, LLC
    Inventor: Jhy-Jhu Lin